Mobile menu icon
Mobile menu icon Search iconSearch
Search type

News

There's always something new to read about the Faculty, whether it's a new discovery by one of our academics, an award won by one of our students, or an upcoming event.

Most press releases will specify media contacts, but if in doubt, please get in touch with our Media Relations Officer, Michael Addelman, at michael.addelman@manchester.ac.uk or on +44 (0)161 275 2111.

Latest news

COVID: The three barriers that stop people being vaccinated
(18 June 2021)

Getting everyone in a country vaccinated is like watching software updates load: it whizzes along for the first 80% or so and then seems to take forever to finish the rest. Around 80% of the UK adult population has received at least one dose of the vaccine.

To fully vaccinate all adults is going to take a final big push. For it to be successful, those responsible for the vaccine rollout need to ensure that the public are sufficiently capable, have sufficient opportunity, and are sufficiently motivated to take the vaccine.

Capability is about having the knowledge and skills to take up the vaccine. For example, some people might not have had enough information to convince them that the vaccine is safe. They may not know when, where and how to get the vaccine. Or they may not be able to make plans to have the vaccine.

Opportunity is about having the necessary conditions to take up the vaccine. For example, someone might not have the encouragement or social support from family and friends. Or the vaccine might not be available in their region, so they don’t have the opportunity to be immunised.

Motivation is about having the desire to have the vaccine. For example, some people might not believe the vaccine will protect them from COVID-19, or they may not be able to overcome their fear of needles.

People differ in their capabilities, opportunities and motivations, so steps to increase vaccination uptake need to target the appropriate barrier. For example, it is not helpful to tell people about the positive outcomes of COVID-19 vaccination if the vaccination isn’t available to them. It would be irresponsible to increase people’s fear by telling them about the health risks of not vaccinating but not ensure they can easily get to the vaccination centres at a time that’s convenient for them.

New guidance

Researchers in the UK recently reviewed the evidence about what works to encourage people to take up vaccinations in pandemics and epidemics. They found that the focus of previous interventions were mainly on changing capability (explaining why vaccines are safe and correcting misunderstandings) and motivation (telling people about the benefits of vaccination). There was little in the interventions that seemed to address opportunities.

This research formed the basis of a guidance, written by the British Psychological Society, to be considered by people in public health when trying to get people to have the vaccine. It recognised that people’s capability, opportunity and motivation to take up the vaccine differed because of factors that are often outside of people’s control.

For example, some countries have low opportunity because of the cost of the vaccine prevents mass vaccination. Some people may have low capability as there may not be enough information about vaccine safety for their particular group – for example, pregnant women. And some people may have low motivation if they are afraid of leaving the home after shielding.

A person can have different capability, opportunity and motivation over time. For instance, some may worry more about vaccine safety for the first dose but have problems with opportunity, because of a lack of local vaccination sites, for the second dose. Public health experts need to address all of these barriers to ensure that people can have the vaccine so we can all be protected from COVID-19 and get back to normal life.The Conversation

Tracy Epton, Lecturer in Health Psychology, University of Manchester

This article is republished from The Conversation under a Creative Commons license. Read the original article.

New guide launched to help challenge Covid conspiracy theories
(18 June 2021)

A new guide has been launched to help science communicators to have conversations with individuals who buy into coronavirus conspiracy theories.

Investment for rare disease research by great ormond street hospital children’s charity
(17 June 2021)

Great Ormond Street Hospital Children’s Charity (GOSH Charity) has announced a £2.5 million investment into 11 pioneering child health research projects - including one at The University of Manchester. The funding is the UK’s largest charitable grant-making scheme of its kind dedicated to paediatric rare disease research.

Is the UK government’s clean air approach good enough?
(17 June 2021)

Poor air quality is the biggest environmental health issue facing the UK, linked to an estimated 64,000 deaths a year, disproportionately affecting disadvantaged communities, and tackling this crisis should be at the top of everyone’s agenda.

Mould exposure significantly increased chance of COPD flare up in study
(14 June 2021)

Patients with a common respiratory disease had more flare-ups linked to activities that put them at risk of being exposed to mould in a study by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) researchers.

Fitbits could help patients recover faster from surgery
(14 June 2021)

Smartwatches could help prepare patients for major surgery, improving their recovery, researchers at The Christie NHS Foundation Trust in Manchester have found in a study sppnsored by The Univesity of Manchester.

Numbers of GPs wanting to leave already high before COVID, finds survey
(10 June 2021)

The number of GPs who say they were likely to quit direct patient care within five years was 37%, even before the coronavirus pandemic, according to a new survey carried out by University of Manchester researchers.

Study reveals worrying disparity in excess deaths during pandemic
(7 June 2021)

A study led by researchers at the Universities of Manchester and York published in The Lancet Regional Health – Europe today (07/06/21) has revealed strong disparities in rates of excess deaths in England and Wales during the first 30 weeks of the COVID-19 pandemic.

Women’s stronger immune response could protect from some skin cancers
(3 June 2021)

Women may have a stronger immune response to a common form of skin cancer than men, according to early research on mice and human cells.

Hearing loss in older people can be preventable while young, argue experts
(1 June 2021)

A new model by University of Manchester researchers has proposed a way to prevent hearing loss in older people by addressing socioeconomic inequalities encountered while young.

University bags global citizenship award for healthcare initiative
(27 May 2021)

A University of Manchester initiative which engages its students’ healthcare improvement work in hard to reach communities in the UK and beyond has come third in a prestigious international prize for global citizenship.

New study investigates diagnostic errors in English general practice
(25 May 2021)

More than half (58%) of diagnostic errors in general practice happen during GP consultations with patients, according to new research which investigated this across general practice in England for the first time.

New research reveals why some people do not receive NICE recommended care following self-harm
(25 May 2021)

For the first time, researchers have looked in detail at the reasons why some people do not receive the care that they need when they attend emergency departments following self-harm. This new research was co-designed and co-authored with people who have lived experience of mental health services and self-harm.

New research calls for better care for people who seek emergency help following self-harm
(25 May 2021)

Research has found that people who go to A&E following self-harm receive varying quality of care and this has a significant impact on what they experience subsequently.

Type 2 diabetes missed or diagnosis delayed for 60,000 UK people in 2020
(17 May 2021)

Researchers investigating the impact of COVID-19 on the NHS in the UK reviewed the health records of 14 million people between March and December 2020 and found that the diagnosis of type 2 diabetes was missed or delayed for 13,700 people. When the findings were expanded to the total population of the UK, the researchers estimated that the figure stands at around 60,000 people.

One in nine adults struggled with mental health during pandemic, find researchers
(7 May 2021)

One in nine adults consistently had very poor or deteriorating mental health during the first six months of the Covid-19 pandemic according to new research.

‘Causal’ blood pressure genes found in the human kidney
(6 May 2021)

An international team of scientists led by The University of Manchester have discovered 179 kidney genes responsible for high blood pressure.

Vulnerable older people at greater risk of depression and anxiety during pandemic
(5 May 2021)

Older people who are clinically vulnerable to COVID-19 are at greater risk of deterioration in health and social well-being during the pandemic, according to a new study.

Gerald Chan made Honorary Professor at The University of Manchester
(27 April 2021)

Renowned scientist and venture capitalist, Dr Gerald Chan, has been made an Honorary Professor of Translational Medicine at the University of Manchester.

Hospitalised shift workers up to 3 times more likely to be Covid-19 positive
(27 April 2021)

Scientists have found an association between shift work and COVID-19 positivity in hospitalised patients.

New drug is gamechanger in psoriasis treatment
(23 April 2021)

A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.

Scientists cast new understanding of how skin repairs itself
(22 April 2021)

University of Manchester scientists have cast new light on how our skin repairs itself, bringing the possibility of regeneration of the organ a step closer.

Toothache sufferers turn to antibiotics for ‘cure’ on social media
(21 April 2021)

Social media is used extensively to seek antibiotics, avoid dental treatment and provide support to people with toothache, according to new research.

Explore hidden world of microbes in new comic book
(21 April 2021)

Research led by University of Manchester scientists has inspired a comic book aiming to help young people aged 10 and above understand the wonder of microbes.

Altered immune signature linked to Long-Covid
(14 April 2021)

University of Manchester scientists have discovered a persistent alteration in the immune system of patients, six months after they have been hospitalised for Covid-19 which could be associated with poorer health outcomes.

Fungal disease diagnosis is life saver for patients with HIV and AIDS
(12 April 2021)

A fungal disease diagnostic and educational programme has had a transformational impact on the mortality of HIV patients in Guatemala, according to new research.

New national study of long-term impacts of debilitating lung damage from COVID-19
(7 April 2021)

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Surveillance system tracks Covid infection hotspots in hospital
(30 March 2021)

A University of Manchester team has applied new techniques to detect and track the transmission of Covid-19 in hospital.

Early breast cancer care largely safe and effective in pandemic
(29 March 2021)

A UK-wide study involving patients with early breast cancer has shown their care was no less safe and effective than before the pandemic started.

Brain implant firm wins £12m funding with Graphene@Manchester nanotech
(29 March 2021)

A collaboration between two Barcelona institutions and the Nanomedicine Lab at The University of Manchester - aimed at treating brain disorders such as epilepsy and Parkinson’s Disease - has secured £12m in funding.